New cancer drug combo enters human testing for Tough-to-Treat colon cancer
NCT ID NCT07283367
Summary
This clinical trial is testing a new combination treatment called HS-20110 in patients with advanced colorectal cancer that has spread. The study aims to find the safest and most effective dose and see how well the treatment works to control the cancer. It will involve 502 adult patients at multiple medical centers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRC are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.